These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 8941467)

  • 21. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
    Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
    Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
    Ismail-Beigi F; Craven TE; O'Connor PJ; Karl D; Calles-Escandon J; Hramiak I; Genuth S; Cushman WC; Gerstein HC; Probstfield JL; Katz L; Schubart U;
    Kidney Int; 2012 Mar; 81(6):586-94. PubMed ID: 22166848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.
    Duckworth W; Marcelli M; Padden M; Kellick K; Duhancik T; Wilhardt M; Colgan K; Romie A
    J Manag Care Pharm; 2003; 9(3):256-62. PubMed ID: 14613469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus.
    Pitale S; Kernan-Schroeder D; Emanuele N; Sawin C; Sacks J; Abraira C;
    J Diabetes Complications; 2005; 19(4):207-11. PubMed ID: 15993354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1998 Jul; 116(7):874-86. PubMed ID: 9682700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of glucose control.
    Edelman SV
    Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
    Rosenstock J; Meisel A; Raskin P
    Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin].
    Nauck M; del Prato S; Meier JJ; Durán-García S; Rohwedder K; Elze M; Parikh SJ
    Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S6-15. PubMed ID: 23529570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study.
    Del Prato S; Camisasca R; Wilson C; Fleck P
    Diabetes Obes Metab; 2014 Dec; 16(12):1239-46. PubMed ID: 25132212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
    Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
    Turner R; Cull C; Holman R
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice.
    Vähätalo M; Rönnemaa T; Viikari J
    Scand J Prim Health Care; 2007 Sep; 25(3):147-53. PubMed ID: 17846932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of medical therapies on retinopathy progression in type 2 diabetes.
    ; ; Chew EY; Ambrosius WT; Davis MD; Danis RP; Gangaputra S; Greven CM; Hubbard L; Esser BA; Lovato JF; Perdue LH; Goff DC; Cushman WC; Ginsberg HN; Elam MB; Genuth S; Gerstein HC; Schubart U; Fine LJ
    N Engl J Med; 2010 Jul; 363(3):233-44. PubMed ID: 20587587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and progression of retinopathy after inpatient management of diabetes.
    Kawasaki S; Hasegawa O; Satoh S; Saito T; Ishio H; Fukushima H; Kato S; Yamashita H; Terauchi Y; Sekihara H
    Intern Med; 2006; 45(22):1267-71. PubMed ID: 17170499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.